Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 May 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 8 results:
[ Author(Desc)] Title Type Year
Filters: Author is Strongman, H.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
H. Strongman, Kausar, I., and Maher, T. M., Incidence, Prevalence, and Survival of Patients with Idiopathic Pulmonary Fibrosis in the UK, Adv Ther, vol. 35, pp. 724-736, 2018.
H. Strongman, Christopher, S., Majak, M., Williams, R., Bahmanyar, S., Linder, M., Heintjes, E. M., Bennett, D., Korhonen, P., and Hoti, F., Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study, BMJ Open Diabetes Res Care, vol. 6, p. e000481, 2018.
H. Strongman, D'Oca, K., Langerman, H., and Das, R., Comparison of diabetes-associated secondary healthcare utilization between alternative oral antihyperglycaemic dual therapy combinations with metformin in patients with type 2 diabetes: an observational cohort study, Diabetes Obes Metab, vol. 17, pp. 573-80, 2015.
H. Strongman, Brown, A., Smeeth, L., and Bhaskaran, K., Body mass index and Hodgkin's lymphoma: UK population-based cohort study of 5.8 million individuals, Br J Cancer, 2019.
H. Strongman, Williams, R., Meeraus, W., Murray-Thomas, T., Campbell, J., Carty, L., Dedman, D., Gallagher, A., Oyinlola, J., Kousoulis, A., and Valentine, J., Limitations for health research with restricted data collection from UK primary care, Pharmacoepidemiol Drug Saf, 2019.
H. Strongman, Gadd, S., Matthews, A., Mansfield, K. E., Stanway, S., Lyon, A. R., dos-Santos-Silva, I., Smeeth, L., and Bhaskaran, K., Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases, Lancet, 2019.
H. Strongman, Korhonen, P., Williams, R., Bahmanyar, S., Hoti, F., Christopher, S., Majak, M., Kool-Houweling, L., Linder, M., Dolin, P., and Heintjes, E. M., Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study, BMJ Open Diabetes Res Care, vol. 5, p. e000364, 2017.
H. Strongman, Williams, R., and Bhaskaran, K., What are the implications of using individual and combined sources of routinely collected data to identify and characterise incident site-specific cancers? a concordance and validation study using linked English electronic health records data, BMJ Open, vol. 10, p. e037719, 2020.
[Page last reviewed 4 May 2021]